Literature DB >> 11348017

Molecular mechanisms of CD40 signaling.

G A Bishop1, B S Hostager.   

Abstract

CD40, a member of the growing tumor necrosis factor receptor (TNF-R) family of molecules, functions as a transmembrane signal receptor in both hematopoietic and non-hematopoietic cell types, although its physiological roles are less well understood in the latter. Much has been learned over the past decade about the role of CD40 signaling in various cellular functions. In addition, some of the molecular events which occur subsequent to CD40 engagement have been characterized, although much remains to be understood. This review will summarize the known important biological roles of CD40, and discuss what is currently known about how CD40 signals.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11348017

Source DB:  PubMed          Journal:  Arch Immunol Ther Exp (Warsz)        ISSN: 0004-069X            Impact factor:   4.291


  14 in total

1.  Differential signaling and tumor necrosis factor receptor-associated factor (TRAF) degradation mediated by CD40 and the Epstein-Barr virus oncoprotein latent membrane protein 1 (LMP1).

Authors:  K D Brown; B S Hostager; G A Bishop
Journal:  J Exp Med       Date:  2001-04-16       Impact factor: 14.307

2.  Syk mediates BCR- and CD40-signaling integration during B cell activation.

Authors:  Haiyan Ying; Zhenping Li; Lifen Yang; Jian Zhang
Journal:  Immunobiology       Date:  2010-10-07       Impact factor: 3.144

3.  Sensitization to minor antigens is a significant barrier in bone marrow transplantation and is prevented by CD154:CD40 blockade.

Authors:  H Xu; Y Huang; L R Hussain; Z Zhu; L D Bozulic; C Ding; J Yan; S T Ildstad
Journal:  Am J Transplant       Date:  2010-07       Impact factor: 8.086

4.  Humoral immunity is the dominant barrier for allogeneic bone marrow engraftment in sensitized recipients.

Authors:  Hong Xu; Paula M Chilton; Michael K Tanner; Yiming Huang; Carrie L Schanie; Mariano Dy-Liacco; Jun Yan; Suzanne T Ildstad
Journal:  Blood       Date:  2006-08-03       Impact factor: 22.113

5.  Costimulatory blockade of CD154-CD40 in combination with T-cell lymphodepletion results in prevention of allogeneic sensitization.

Authors:  Hong Xu; Jun Yan; Yiming Huang; Paula M Chilton; Chuanlin Ding; Carrie L Schanie; Li Wang; Suzanne T Ildstad
Journal:  Blood       Date:  2007-09-07       Impact factor: 22.113

Review 6.  Rethinking the metastatic cascade as a therapeutic target.

Authors:  Lida A Mina; George W Sledge
Journal:  Nat Rev Clin Oncol       Date:  2011-04-19       Impact factor: 66.675

7.  Innate and adaptive immune responses are tolerized in chimeras prepared with nonmyeloablative conditioning.

Authors:  Hong Xu; Ziqiang Zhu; Yiming Huang; Larry D Bozulic; Lala-Rukh Hussain; Jun Yan; Suzanne T Ildstad
Journal:  Transplantation       Date:  2012-03-15       Impact factor: 4.939

8.  Inducible CD40 expression mediates NFkappaB activation and cytokine secretion in human colonic fibroblasts.

Authors:  C M Gelbmann; S N Leeb; D Vogl; M Maendel; H Herfarth; J Schölmerich; W Falk; G Rogler
Journal:  Gut       Date:  2003-10       Impact factor: 23.059

9.  Interleukin-6 production in CD40-engaged fibrocytes in thyroid-associated ophthalmopathy: involvement of Akt and NF-κB.

Authors:  Erin F Gillespie; Nupur Raychaudhuri; Konstantinos I Papageorgiou; Stephen J Atkins; Ying Lu; Laya K Charara; Tünde Mester; Terry J Smith; Raymond S Douglas
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-11-21       Impact factor: 4.799

10.  Transmembrane peptides used to investigate the homo-oligomeric interface and binding hotspot of latent membrane protein 1.

Authors:  Deanne W Sammond; Catherine Joce; Ryan Takeshita; Sarah E McQuate; Nilanjan Ghosh; Jennifer M Martin; Hang Yin
Journal:  Biopolymers       Date:  2011-05-10       Impact factor: 2.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.